Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat

Previous work has established the existence of dystrophin–nitric oxide (NO) signaling to histone deacetylases (HDACs) that is deregulated in dystrophic muscles. As such, pharmacological interventions that target HDACs (that is, HDAC inhibitors) are of potential therapeutic interest for the treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Consalvi, Silvia, Mozzetta, Chiara, Bettica, Paolo, Germani, Massimiliano, Fiorentini, Francesco, Del Bene, Francesca, Rocchetti, Maurizio, Leoni, Flavio, Monzani, Valmen, Mascagni, Paolo, Puri, Pier Lorenzo, Saccone, Valentina
Formato: Artigo
Idioma:Inglês
Publicado em: ScholarOne 2013
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3667212/
https://ncbi.nlm.nih.gov/pubmed/23552722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2013.00011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados